Harnessing oncolytic viruses to overcome immunosuppression in breast cancer: from mechanisms to clinical translation. [PDF]
Xianshu K +6 more
europepmc +1 more source
SLUR(M)-py: a SLURM powered Pythonic pipeline for parallel processing of 3D (Epi)genomic profiles. [PDF]
Roth C +4 more
europepmc +1 more source
BAP1 as a predictive biomarker of therapeutic response to oncolytic vaccinia virus for metastatic renal cell carcinoma therapy. [PDF]
Park JS +6 more
europepmc +1 more source
Giant virus genomes are unlikely to be reservoirs of antibiotic resistance genes. [PDF]
Barth ZK.
europepmc +1 more source
STING-mediated antiviral response: insights into MVA replication control in avian cells. [PDF]
Brusco T +11 more
europepmc +1 more source
Mpox-Specific Neutralizing Antibodies up to 9 Months Following 1 or 2 Doses of Intradermal MVA-BN Vaccination in Sweden. [PDF]
Espinosa-Gongora C +11 more
europepmc +1 more source
Optimal deployment of limited vaccine supplies to control mpox outbreaks. [PDF]
Berry MT +5 more
europepmc +1 more source
Mpox Among Pregnant Women and Their Infants in the U.S. Outbreak, 2022-2023. [PDF]
Roth NM +25 more
europepmc +1 more source

